Skip to search formSkip to main contentSkip to account menu

Dibekacin

Known as: 3',4' Dideoxykanamycin B, B, 3',4'-Dideoxykanamycin, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-2-deoxy- 
An aminoglycoside antibiotic derived from kanamycin B. Dibekacin is active against bacterial strains that are resistant to kanamycin.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Corn plant arrangement is one of the most important management tool to improve solar radiation interception and it can be done… 
2007
2007
BackgroundThe present study was undertaken to examine whether antibiotic-impregnated calcium phosphate cement (CPC) would provide… 
1987
1987
Four multiband compression limiters and two linear amplification systems were compared in terms of the intelligibility of… 
Highly Cited
1985
Highly Cited
1985
The resistance mechanisms of more than 2,000 aminoglycoside-resistant gram-negative aerobic bacteria were estimated by a method… 
Highly Cited
1983
Highly Cited
1983
Like many amphiphilic cationic drugs, aminoglycosides are able to produce phospholipidosis, mainly by inhibiting enzymes involved… 
Highly Cited
1976
Highly Cited
1976
A total of 319 clinical isolates known to be resistant to one or more aminoglycoside antibiotics were tested for their… 
1976
1976
The effect of antibiotics on phagocytosis and killing of Pseudomonas aeruginosa by rabbit polymorphonuclear leukocytes was… 
1975
1975
A clinical isolate Pseudomonas aeruginosa GN315 resistant to amikacin (AK), a new semisynthetic antibiotic, inactivated AK by…